Nasal COVID-19 Vaccine for Booster Dose Cleared by Indian Government
The Indian drug regulator has approved Bharat Biotech’s iNCOVACC, an intranasal Covid-19 vaccine, for use as a booster dose, and it is a mix-and-match dose following the primary dose. iNCOVACC has been approved for limited emergency use on patients over the age of 18 as a heterologous booster following two doses of either Covaxin or […]
Continue Reading